海正药业：法维拉韦片线下进院全面推广并上线电商

Core Viewpoint - The company, Haizheng Pharmaceutical, highlights the potential of its product Favipiravir tablets (Hai Fukan) as a broad-spectrum antiviral agent with low resistance, indicating its applicability against various RNA viruses [1] Group 1: Product Information - Favipiravir tablets are characterized as an RNA polymerase inhibitor, showcasing broad-spectrum antiviral properties and low resistance [1] - The company is actively promoting the accessibility and awareness of the product by integrating internal and external resources [1] Group 2: Sales and Distribution - Offline sales efforts, including hospital access, are being comprehensively promoted [1] - Patients can also purchase the product through e-commerce channels, enhancing its availability [1]